Description
This product utilizes regulatory B cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone I1DFG2-24). We employs the pUC (T7-RFP-IL-10-SpeI) vector components and the SynExpress system of the introns Knock-in/Balancing feedback for a robust and sustained response against cancers.
Host
Human
Target
CD22
Clone
I1DFG2-24
Species Reactivity
Human
Cell Source
Regulatory B cells
Sensor Gene
RFP
Promoter
T7
Effector Gene
IL-10
Insertion Sites
SpeI
Gene Modification
Knock-in
Modification Domain
Introns
Carrier Type
pUC
Transformation Accuracy
0.99
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.